Chlamydia and Mycoplasma in Coronary Artery Disease

NCT00561028 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 138

Last updated 2007-11-20

No results posted yet for this study

Summary

To test the association between anti-Chlamydia serum titers and anti-Mycoplasma antibodies with Acute Coronary Syndromes.

Conditions

Interventions

OTHER

blood sample analysis - mycoplasma and chlamydia antibodies

Anti-Chlamydia and anti-Mycoplasma IgG antibodies were measured by indirect immunofluorescence at baseline (24 hours of hospitalization) and after 6 months (follow-up).

Sponsors & Collaborators

  • University of Sao Paulo

    collaborator OTHER
  • Hospital de Base

    lead OTHER

Principal Investigators

  • Jose C Nicolau, MD, pHD · University of Sao Paulo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-03-31
Completion
2004-11-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00561028 on ClinicalTrials.gov